Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Lalloo

Showing results (51-60 of 162) with videos related to

Pageof 17
Sort By:
European Journal of Human Genetics : EJHG|May 13, 2004
BRCA1/2 predictive testing: a study of uptake in two centresLucy Brooks, Fiona Lennard, Andrew Shenton, et al.
Journal of Medical Genetics|July 21, 2009
Breast cancer susceptibility variants alter risks in familial diseaseAyse Latif, Kristen D Hadfield, Stephen A Roberts, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancerLouise M Byrd, Andrew Shenton, Eamonn R Maher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2013
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriersD Gareth R Evans, Sarah L Ingham, Iain Buchan, et al.
European Journal of Human Genetics : EJHG|August 22, 2023
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndromeFiona Lalloo, Anju Kulkarni, Cindy Chau, et al.
European Journal of Human Genetics : EJHG|June 9, 2016
Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testingHelen Byers, Yvonne Wallis, Elke M van Veen, et al.
European Journal of Human Genetics : EJHG|March 3, 2021
Germline FFPE inherited cancer panel testing in deceased family members: implications for clinical management of unaffected relativesSarah Bennett, Elizabeth Alexander, Harry Fraser, et al.
Health Technology Assessment (Winchester, England)|September 9, 2024
Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluationTristan M Snowsill, Helen Coelho, Nia G Morrish, et al.
World Journal of Gastrointestinal Oncology|February 22, 2019
Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practiceAlexander Jp Fulton, Angela Lamarca, Christina Nuttall, et al.
International Journal of Cancer|May 2, 2007
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation statusPal Moller, D Gareth Evans, Marta M Reis, et al.
Pageof 17

Showing results (51-60 of 162) with videos related to

Sort By:
Pageof 17
European Journal of Human Genetics : EJHG|May 13, 2004
BRCA1/2 predictive testing: a study of uptake in two centresLucy Brooks, Fiona Lennard, Andrew Shenton, et al.
Journal of Medical Genetics|July 21, 2009
Breast cancer susceptibility variants alter risks in familial diseaseAyse Latif, Kristen D Hadfield, Stephen A Roberts, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancerLouise M Byrd, Andrew Shenton, Eamonn R Maher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2013
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriersD Gareth R Evans, Sarah L Ingham, Iain Buchan, et al.
European Journal of Human Genetics : EJHG|August 22, 2023
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndromeFiona Lalloo, Anju Kulkarni, Cindy Chau, et al.
European Journal of Human Genetics : EJHG|June 9, 2016
Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testingHelen Byers, Yvonne Wallis, Elke M van Veen, et al.
European Journal of Human Genetics : EJHG|March 3, 2021
Germline FFPE inherited cancer panel testing in deceased family members: implications for clinical management of unaffected relativesSarah Bennett, Elizabeth Alexander, Harry Fraser, et al.
Health Technology Assessment (Winchester, England)|September 9, 2024
Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluationTristan M Snowsill, Helen Coelho, Nia G Morrish, et al.
World Journal of Gastrointestinal Oncology|February 22, 2019
Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practiceAlexander Jp Fulton, Angela Lamarca, Christina Nuttall, et al.
International Journal of Cancer|May 2, 2007
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation statusPal Moller, D Gareth Evans, Marta M Reis, et al.
Pageof 17